HPV testing 2

• FC 10-01 • Pilot study on use of INNO-LiPA ® HPV Genotyping Extra II with Colli-Pee collected UCM preserved urine See abstract > J. J. PATTYN • FC 10-02 • Evaluation of BD onclarity in detection of cancer and pre-cancer in women with ASCUS/LSIL in China See abstract > M. M. JIANG • FC 10-03 • Analytical stability of SurePath collected cervical smear samples for HPV testing See abstract > A. A.H. SAID AL-FATTAL • FC 10-04 • Valgent-4 clinical validation of three HPV Genotyping Tests on SurePath screening samples from the Danish carvical screening program See abstract > M. M. VIK HESSNER JOCHUMSEN • FC 10-05 • Optimization of the RIATOL qPCR HPV genotyping assay by choosing a threshold assuring satisfactory accuracy to detect high grade cervical intraepithelial neoplasia See abstract > L. L. XU • FC 10-06 • Evaluation of Xpert ® HPV in cervical specimens collected in Surepath preservative fluid: an interim analysis See abstract > D. D. VANDEN BROECK • FC 10-07 • Reproducibility of human papilloma virus typing with Xpert Real-Time PCR on archival cytology samples See abstract > M. M. TAUBER • FC 10-08 • Development of a novel multiplex type-specific quantitative real-time PCR for detection and differentiation of infections with HPV2, HPV27, and HPV HPV57 See abstract > L. L. HOSNJAK • FC 10-09 • The 5-year incidence and clearance of type-specific HPV in a screening cohort in China See abstract > R. R. REZHAKE